Center for Scientific Review; Notice of Closed Meetings, 63969-63971 [2023-20104]

Download as PDF Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices Lanette A. Palmquist, Project Clearance Liaison, National Institute on Drug Abuse, National Institutes of Health. [FR Doc. 2023–20075 Filed 9–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Minority Health and Health Disparities; Notice of Closed Meetings lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; NIMHD Mentored Career and Research Development Awards (Ks). Date: October 26–27, 2023. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIMHD, DEM II, Suite 800, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Deborah Ismond, Ph.D., Scientific Review Officer, Office of Extramural Research Administration, National Institute on Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, (301) 594–2704, ismonddr@mail.nih.gov. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50—Clinical Trial Optional). Date: November 1–2, 2023. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIMHD, DEM II, Suite 800, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Maryline Laude-Sharp, Ph.D., Scientific Review Officer, Office of Extramural Research Administration, National Institute on Minority Health and Health Disparities, National Institutes of VerDate Sep<11>2014 18:29 Sep 15, 2023 Jkt 259001 Health, 6707 Democracy Boulevard, Suite 800, Bethesda, MD 20892, 301–451–9536, mlaudesharp@mail.nih.gov. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; Community Level Interventions to Improve Minority Health and Reduce Health Disparities. Date: November 9, 2023. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIMHD, DEM II, Suite 800, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ivan K. Navarro, Ph.D., Scientific Review Officer, Office of Extramural Research Administration National Institute on Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, 301–827–2061, ivan.navarro@nih.gov. Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; NIMHD Support for Conferences and Scientific Meetings (R13). Date: November 14, 2023. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIMHD, DEM II, Suite 800, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Xinli Nan, M.D., Ph.D., Scientific Review Officer, Office of Extramural Research Activities National Institute on Minority Health and Health Disparities, National Institutes of Health, 6707 Democracy Boulevard, Suite 800, Bethesda, MD 20892, (301) 594–7784, Xinli.Nan@nih.gov. Dated: September 12, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. 63969 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Special Emphasis Panel; Conflicting Application Review of NRRC Meeting. Date: October 10, 2023. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Nursing Research, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joshua Wolff, Ph.D., Scientific Review Officer/Social & Behavioral Scientist, Scientific Review Branch, National Institute of Nursing Research, 6701 Democracy Boulevard, Bethesda, MD 20892, 301–793–5758, Joshua.wolff@nih.gov. Name of Committee: National Institute of Nursing Research Special Emphasis Panel; NINR T32 Training Grant Applications Review Meeting. Date: October 26, 2023. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Nursing Research, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nisan Bhattacharyya, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Nursing Research, 6701 Democracy Boulevard, Room 720, Bethesda, MD 20892, 301–435–6979, nisan.bhattacharyya@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: September 12, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–20061 Filed 9–15–23; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2023–20058 Filed 9–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review; Notice of Closed Meetings National Institute of Nursing Research; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\18SEN1.SGM 18SEN1 63970 Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Clinical Neuroplasticity and Neurotransmitters Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Capitol, 550 C Street SW, Washington, DC 20024. Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301–435– 1259, nadis@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Biochemistry and Biophysics of Membranes Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015. Contact Person: Nuria E Assa-Munt, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 20892, (301) 451– 1323, assamunu@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC 20037. Contact Person: Salma Asmat Quraishi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–0592, salma.quraishi@ nih.gov. Name of Committee: Biology of Development and Aging Integrated Review Group; Drug Discovery and Molecular Pharmacology C Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeffrey Smiley, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, (301) 272– 4596, smileyja@csr.nih.gov Name of Committee: Applied Immunology and Disease Control Integrated Review Group; Transmission of Vector-Borne and Zoonotic Diseases Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 8:00 p.m. VerDate Sep<11>2014 18:29 Sep 15, 2023 Jkt 259001 Agenda: To review and evaluate grant applications. Place: Crowne Plaza National Airport, 1480 Crystal Drive, Arlington, VA 22202. Contact Person: Haruhiko Murata, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–3245, muratah@csr.nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Lifestyle Change and Behavioral Health Study Section. Date: October 12–13, 2023. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Marriott, 1999 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 827–6401, pamela.jeter@nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Oral, Dental and Craniofacial Sciences Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda One, Bethesda Metro Center, Bethesda, MD 20814. Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, (301) 435– 1781, liuyh@csr.nih.gov. Name of Committee: Population Sciences and Epidemiology Integrated Review Group; Reproductive, Perinatal and Pediatric Health Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: Cambria Hotel College Park, 8321 Baltimore Avenue, College Park, MD 20740. Contact Person: Cynthia Chioma McOliver, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 594–2081, mcolivercc@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Clinical Data Management and Analysis Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shivakumar V Chittari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 408–9098, chittari.shivakumar@ nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Group; Therapeutic Immune Regulation Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Yue Wu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 803C, Bethesda, MD 20892, (301) 867–5309, wuy25@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Science of Implementation in Health and Healthcare Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Wenjuan Wang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480–8667, wangw22@mail.nih.gov. Name of Committee: Risk, Prevention and Health Behavior Integrated Review Group; Interventions to Prevent and Treat Addictions Study Section. Date: October 12–13, 2023. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Izabella Zandberg, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301–594–0359, izabella.zandberg@nih.gov. Name of Committee: Integrative, Functional and Cognitive Neuroscience Integrated Review Group; Sensory-Motor Neuroscience Study Section. Date: October 12–13, 2023. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alena Valeryevna Savonenko, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 594– 3444, savonenkoa2@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Cell Structure and Function 1 Study Section Date: October 12–13, 2023. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Dr, Bethesda, MD 20817 (Virtual Meeting). Contact Person: Jessica Smith, Ph.D., Scientific Review Officer, Center for E:\FR\FM\18SEN1.SGM 18SEN1 Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301.402.3717, jessica.smith6@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 12, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–20104 Filed 9–15–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–6086–N–07] RIN 2577–AD05 Economic Growth Regulatory Relief and Consumer Protection Act: Implementation of National Standards for the Physical Inspection of Real Estate (NSPIRE); Extension of Compliance Date Office of the Assistant Secretary for Community Planning and Development, U.S. Department of Housing and Urban Development (HUD). ACTION: Notice. AGENCY: This notice extends the compliance date for HUD’s National Standards for the Physical Inspection of Real Estate (NSPIRE) final rule for Community Planning and Development (CPD) programs. Specifically, HUD is extending the compliance date for the HOME Investment Partnerships Program (HOME) and Housing Trust Fund (HTF), Housing Opportunities for Persons With AIDS (HOPWA), Emergency Solution Grants (ESG) and Continuum of Care (COC) programs (‘‘CPD programs’’) until October 1, 2024. HUD is taking this action to allow jurisdictions, participants, and grantees additional time to incorporate HUD’s NSPIRE standards specific to their own programs and the flexibility to transition to NSPIRE under their own timelines. DATES: Compliance Date: Jurisdictions, participants, and grantees subject to 24 CFR parts 92, 93, 574, 576, and 578, are not required to comply with the changes to these parts in the NSPIRE final rule until October 1, 2024. FOR FURTHER INFORMATION CONTACT: Caitlin Renner, Supervisory Affordable Housing Specialist, Room 7160, Department of Housing and Urban Development, 451 Seventh Street SW, Washington, DC 20410–7000; telephone lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 18:29 Sep 15, 2023 Jkt 259001 (202) 708–2684. (This is not a toll-free number). HUD welcomes and is prepared to receive calls from individuals who are deaf or hard of hearing, as well as individuals with speech or communication disabilities. To learn more about how to make an accessible telephone call, please visit: https://www.fcc.gov/consumers/guides/ telecommunications-relay-service-trs. SUPPLEMENTARY INFORMATION: I. Background The Economic Growth Regulatory Relief and Consumer Protection Act: Implementation of National Standards for Physical Inspection of Real Estate (NSPIRE) final rule (‘‘NSPIRE final rule’’) was published on May 11, 2023 (88 FR 30442). The NSPIRE final rule strengthens HUD’s physical condition standards and re-envisions how HUDassisted housing is inspected by aligning and consolidating the inspection regulations. The NSPIRE final rule included amendments to 24 CFR parts 92, 93, 574, 576, and 578 to conform their various inspection requirements to NSPIRE and established an effective date for these amendments of October 1, 2023. The amendments for HOME and HTF require participating jurisdictions to develop property standards that apply the requirements in 24 CFR 5.703 to rental or homeownership projects involving rehabilitation, ongoing inspections of HOME- and HTF-assisted rental housing during the period of affordability, and acquisition of standard housing for homeownership. For HOME, these requirements also apply to units occupied by tenants receiving HOME tenant-based rental assistance. The changes in the NSPIRE final rule further provide that HUD will publish lists of specific deficiencies in a Federal Register notice that must be corrected before HOME or HTF project completion or during the period of affordability for occupied units. HUD has not yet published this notice for HOME or HTF deficiencies, but these deficiencies for HOME and HTF will be a subset of the deficiencies in the NSPIRE Inspection Standards published on June 22, 2023 (the ‘‘NSPIRE Standards’’) for public housing, multifamily housing, and housing choice vouchers/project based vouchers (88 FR 40832). To fully implement the NSPIRE final rule, HOME participating jurisdictions and HTF grantees must develop rehabilitation and ongoing property standards, as well as policies and procedures that incorporate the specific deficiencies that will be published in the notice, applicable PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 63971 requirements in the NSPIRE final rule, and other applicable requirements in the HOME and HTF regulations. II. Basis for Delay of Compliance Date Under the NSPIRE final rule, CPD programs are subject to only the portions of 24 CFR part 5, subpart G that apply to their particular programs. Additionally, different participants may have different implementation needs. For example, some PHAs may be implementing NSPIRE in their voucher program right away, and would therefore benefit from immediate implementation of NSPIRE in their CPD programs, while other participants may have no external need to transition to NSPIRE and would benefit from additional time to implement NSPIRE into their own program. In particular, HOME participating jurisdictions and HTF grantees are not able to update their rehabilitation and ongoing property standards and policies and procedures in accordance with the NSPIRE final rule until HUD publishes the lists of specific deficiencies for HOME and HTF in the Federal Register. This notice will not be published by the effective date of October 1, 2023. HUD recognizes that participating jurisdictions and HTF grantees will not have all the tools to fully implement NSPIRE for HOME and HTF by the effective date. HUD also recognizes that, after HUD publishes the list of specific deficiencies, participating jurisdictions and HTF grantees will need additional time to incorporate the list of specific deficiencies into their rehabilitation and ongoing property standards and policies and procedures. Therefore, for all the reasons stated above, HUD has determined that it is in the public interest to extend the compliance date for all CPD programs to October 1, 2024, to allow participants additional time to transition to NSPIRE. III. Instructions HUD provides the below instructions and guidance specific to particular CPD programs. Instructions for HOME Participating Jurisdictions and HTF Grantees While the NSPIRE final rule applies to projects with HOME or HTF funds committed on or after the effective date of October 1, 2023, HOME participating jurisdictions and HTF grantees do not have to complete implementation of the changes in the NSPIRE rule until the compliance date of October 1, 2024. Participating jurisdictions and grantees should prepare for the compliance date by updating property standard regulatory citations and requirements in E:\FR\FM\18SEN1.SGM 18SEN1

Agencies

[Federal Register Volume 88, Number 179 (Monday, September 18, 2023)]
[Notices]
[Pages 63969-63971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20104]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which

[[Page 63970]]

would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Clinical Neuroplasticity and 
Neurotransmitters Study Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Capitol, 550 C Street SW, Washington, DC 
20024.
    Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Biochemistry and Biophysics of 
Membranes Study Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW, Washington, DC 20015.
    Contact Person: Nuria E Assa-Munt, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4164, MSC 7806, Bethesda, MD 
20892, (301) 451-1323, [email protected].

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Neural Basis of Psychopathology, Addictions 
and Sleep Disorders Study Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC 
20037.
    Contact Person: Salma Asmat Quraishi, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0592, 
[email protected].

    Name of Committee: Biology of Development and Aging Integrated 
Review Group; Drug Discovery and Molecular Pharmacology C Study 
Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Jeffrey Smiley, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 
20892, (301) 272-4596, [email protected]

    Name of Committee: Applied Immunology and Disease Control 
Integrated Review Group; Transmission of Vector-Borne and Zoonotic 
Diseases Study Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza National Airport, 1480 Crystal Drive, 
Arlington, VA 22202.
    Contact Person: Haruhiko Murata, Ph.D., Scientific Review 
Officer, Center for Scientific Review, 6701 Rockledge Drive, 
Bethesda, MD 20892, 301-594-3245, [email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Lifestyle Change and Behavioral Health 
Study Section.
    Date: October 12-13, 2023.
    Time: 8:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crystal City Marriott, 1999 Jefferson Davis Highway, 
Arlington, VA 22202.
    Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 827-6401, 
[email protected].

    Name of Committee: Musculoskeletal, Oral and Skin Sciences 
Integrated Review Group; Oral, Dental and Craniofacial Sciences 
Study Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda One, Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, (301) 435-
1781, [email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Reproductive, Perinatal and Pediatric 
Health Study Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Cambria Hotel College Park, 8321 Baltimore Avenue, 
College Park, MD 20740.
    Contact Person: Cynthia Chioma McOliver, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 
594-2081, [email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Clinical Data Management and Analysis Study 
Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Shivakumar V Chittari, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 408-9098, 
[email protected].

    Name of Committee: Oncology 2--Translational Clinical Integrated 
Review Group; Therapeutic Immune Regulation Study Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Yue Wu, Ph.D., Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 803C, Bethesda, MD 20892, (301) 867-5309, 
[email protected].

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group; Science of Implementation in Health and 
Healthcare Study Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Wenjuan Wang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480-8667, 
[email protected].

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Interventions to Prevent and Treat 
Addictions Study Section.
    Date: October 12-13, 2023.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Izabella Zandberg, Ph.D., Scientific Review 
Officer, Center for Scientific Review, 6701 Rockledge Drive, 
Bethesda, MD 20892, 301-594-0359, [email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Sensory-Motor Neuroscience 
Study Section.
    Date: October 12-13, 2023.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alena Valeryevna Savonenko, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1009J, Bethesda, MD 20892, (301) 
594-3444, [email protected].

    Name of Committee: Cell Biology Integrated Review Group; Cell 
Structure and Function 1 Study Section
    Date: October 12-13, 2023.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Dr, 
Bethesda, MD 20817 (Virtual Meeting).
    Contact Person: Jessica Smith, Ph.D., Scientific Review Officer, 
Center for

[[Page 63971]]

Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892, 301.402.3717, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: September 12, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20104 Filed 9-15-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.